跳至主要内容
临床试验/CTRI/2017/07/009158
CTRI/2017/07/009158招募中不适用

The comparative study of the efficacy of intradermal tranexamic acid V/S 3% topical tranexamic acid V/S topical triple combination (hydroquinone 2 %, tretinion 0.025%, flucinolone acetonide 0.01%) in melasma.

MGM Medical COllege and Hospital1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2016年12月26日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
180
试验地点
1
主要终点
1 To study the efficacy of intradermal tranexamic acid versus topical tranexamic acid versus topical triple combination

研究概览

简要总结

1. Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences. 2014;19(8):753-757.

  1. Bhawan J, Grimes P, Pandya AG,Keady M, Nyers HR, Guevara IL, et al. A histological examination of skin atropy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4% and tretinion 0.05% cream. American Journal of Dermatopathology: December 2009 - Volume 31 - Issue 8 - pp 794-798

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 All melasma patients 2 Willing to give written inform consent.

排除标准

  • 1 Patients with hypersensitivity to drugs 2 Pregnant and lactating patient 3 Patients with clotting disorders or patients who are on anticoagulant therapy.

结局指标

主要结局

1 To study the efficacy of intradermal tranexamic acid versus topical tranexamic acid versus topical triple combination

时间窗: Every Month for 06 months

次要结局

  • To study adverse effects of study drugs

研究者

申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验